A
CASC

Abingworth’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Abingworth’s Portfolio CASC Stock Details CASC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
2017
Q4 		$3.42M Hold
2017
Q3 		$3.78M Hold
2017
Q2 		$3.43M Hold
2017
Q1 		$3.83M Buy